about
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathyNarrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.Effect of swimming on the production of aldosterone in rats.Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension.Role of mineralocorticoid receptor antagonists in cardiovascular disease.Comparison of stress-induced changes in adults and pups: is aldosterone the main adrenocortical stress hormone during the perinatal period in rats?Metabolic syndrome: definitions and controversies.Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.Aldosterone and cardiovascular remodelling: focus on myocardial failure.An ultrastructural analysis of the effects of ethanol self-administration on the hypothalamic paraventricular nucleus in rhesus macaques.Mechanisms of hypertension: the expanding role of aldosterone.Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea?Eplerenone in hypertension.Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene.Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.Oxidative stress in the cardiorenal metabolic syndromeThe Role of Aldosterone in Obesity-Related Hypertension.Immunohistochemistry of the adrenal in primary aldosteronismMineralocorticoid receptor activation in obesity hypertension.Blocking aldosterone in heart failure.Type 2 diabetes mellitus and hypertension: an update.Mineralocorticoid receptor antagonist for renal protection.The role of TGF-β in polycystic ovary syndrome.Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes.Juxtaglomerular Cell Phenotypic Plasticity.Electrolyte-free milk protein solution influences sodium and fluid retention in rats.Suspected transient pseudohypoaldosteronism in a 10-day-old quarter horse foal.A direct relationship between plasma aldosterone and cardiac L-type Ca2+ current in mice.Role of aldosterone in diabetic nephropathy.Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases.Teaching aldosterone regulation and basic scientific principles using a classic paper by Dr. James O. Davis and colleagues.Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
P2860
Q28570951-F324A78C-3975-4E63-B309-3A4A339B08CFQ33667283-E2DFE257-EC05-4DB7-BBCC-0E105C435304Q34301526-7D807184-3819-4453-9D2C-F065FDCCC1FAQ34724494-0634F551-C6B2-491C-84CC-67E1D4165A1DQ34817129-7EAE2305-1031-40EC-BB62-3455E89FB645Q34988344-E04B7B02-A773-4157-8D50-182AD39479ACQ35047747-8A59251B-B413-4144-8F6C-CA7410B559C7Q35113885-32DA044C-15A5-4EE1-B64F-73BF59622A4BQ35770232-A2B2F1AF-02C3-4E5E-9F0B-1FEA8F4147A6Q35847704-4640B48A-849D-41EE-9722-3C322E4CBD75Q35850881-43275DB2-8529-4FF2-B373-49EB6C377593Q35896763-69BA0EB6-D10E-470C-9C42-67D4B14DE1C0Q35967354-E1EA6A37-BD9A-44BF-AF3E-3AF47C5CA824Q36244786-13508AD9-0CF6-4ECC-98EB-3BBDFA2C11A3Q36329456-EB977FD6-FEEA-4EEB-87B5-88CAD2DAB709Q36795759-9B55DEF9-DAF6-4773-B16B-3C4FF8E38EB7Q36950174-0EA9D86A-EB2A-4843-870C-24EC45D8A9B3Q37024315-AF125B0F-3837-4C71-B4B2-25E20884315DQ37517178-66C0229D-996E-452F-956E-F83214F8EF44Q37574673-034584F0-7C5C-4842-A79E-F413CA3F2A8FQ37617567-10EF14D9-FCE3-48C5-B822-09B3380E55D2Q37998573-3390F525-2D4B-49FB-98BE-60B4E7250616Q38098963-2A0597BA-5C3D-4236-ADB0-935746AD71F6Q38221451-514BCB7E-A273-4605-8E78-AD0B1234DDD1Q38533385-5CA5DE16-B231-4BF0-B971-C680A5E66D40Q38741489-3823A6E5-A0C2-4475-8C1E-622316EA5F7AQ39319310-9A0B6045-16C7-4ADA-8962-3404DCCFC48DQ41821592-85676D78-78EE-4906-A92B-E4944DBBA858Q43198526-AA7AC65A-DF48-4FEF-8AF9-5529C85095BDQ46705958-DCF768B4-CD3A-4EA9-B8B7-AF5C58A16A8CQ46713051-75CFD3BF-B7AB-4711-B538-E4696B9F54A3Q46740951-9EBE97B2-EEA0-4399-8A25-6EB8B26AC34BQ46745542-9B91CC3B-5670-4BBD-87A8-FD594D13B5EFQ47292812-F079624F-C648-463B-958C-E432C1AC9B03Q58722306-7A9F3610-735C-4B9F-BF61-1FD88F45C159
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
50th anniversary of aldosterone.
@ast
50th anniversary of aldosterone.
@en
50th anniversary of aldosterone.
@nl
type
label
50th anniversary of aldosterone.
@ast
50th anniversary of aldosterone.
@en
50th anniversary of aldosterone.
@nl
prefLabel
50th anniversary of aldosterone.
@ast
50th anniversary of aldosterone.
@en
50th anniversary of aldosterone.
@nl
P356
P1476
50th anniversary of aldosterone.
@en
P2093
Gordon H Williams
Jonathan S Williams
P304
P356
10.1210/JC.2003-030490
P407
P577
2003-06-01T00:00:00Z